Dr. White also presently serves as President of Tempus Labs (www.tempus.com). Additionally, he holds an appointment at the University of Chicago where he is the James and Karen Frank Family Professor in the Departments of Human Genetics and Medicine, and as Toh Chin Chye Visiting Professor in Molecular Biology and Medicine at National University Singapore. Dr. White is a pioneer in combining experimental and computational techniques to understand the networks of factors that control biological systems during development, disease, and evolution. His team has discovered novel cancer genes in a wide range of tumor types including breast cancer, kidney cancer and myeloid leukemias.
From 2006-2016 he was the Founding Director of the Institute for Genomics & Systems Biology at the University of Chicago, where he built a team of over 120 faculty and staff with approximately $150M in research funding contracts and awards. His academic awards for innovation include the Keck Biomedical Investigator and Beckman Young Investigator awards, and he has also been recognized for his entrepreneurship on the ‘40 under 40’ list by Chicago Crain’s Business. Dr. White has served on the scientific boards of a wide range of start-up biotech companies and foundations.
He also has previously served as acting CEO and co-director of HealthSeq Inc. and HealthSeq Asia Pvt. Ltd., providing hospitals with protected data clouds for analysis of genome and clinical records data. In the non-profit sector he currently holds scientific advisory board positions at institutions that include Harvard University, Yale University, Northwestern University and the National Cancer Institute.
Dr. Grossman has more than 15 years of experience developing cloud computing and high performance computing software that is deployed in industry, government and academia. He is a Professor of Medicine and IGSB Director of Informatics at The University of Chicago. He is an expert in data intensive computing, bioinformatics, cybersecurity, data mining, and large scale data management.
Dr. Patrick Tan holds a joint appointment as Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology, and Research). He directs PRISM, the SingHealth/DukeNUS Precision Medicine Institute. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other honours include the President’s Scholarship, Loke Cheng Kim foundation scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), Singhealth Investigator Excellence Award, Han-Mo Koo Memorial Lectureship (Van Andel Research Institute, USA), Swee Liew Wadsworth Lectureship (NUS), and the Chen New Investigator Award from the Human Genome Organization (HUGO).
In 2015, Dr. Tan received the President’s Science Award, the highest national accolade for scientific achievement. He is an elected member of the American Society for Clinical Investigation (ASCI), and a member of the Bioethics Advisory Committee (BAC), a national body that provides advice to the Singapore government on ethical issues related to biomedical research. He co-leads the biliary tract cancer project of the International Cancer Genome Consortium (ICGC)
Daniel Floerke brings over 25 years of sales and marketing experience to HealthSeq including extensive experience in the biologics manufacturing, molecular diagnostics and human genome sequencing market segments. His goal has always been to bring cutting edge applications and technologies to market. Bringing personalized medicine to the forefront for treating cancer is his true passion. Most recently, he was the Director for Clinical Market Development at Complete Genomics, a human genomics sequencing company. Mr. Floerke has resided in Singapore since 2002, prior to which he lived and worked in Europe and the United States.
Satish has deep experience implementing computing solutions in both academic and industrial environments. Before joining HealthSeq, Satish led Cloud, DevOps and Research initiatives at Accenture and for educational institutes like SMART (Singapore MIT Alliance for Research and Technology) and ACTREC (Advanced Center for Treatment research and Education in Cancer) in the field of Bioinformatics and Cancer Science. Satish has published his work in international journals and was considered a subject matter expert (SME) at Accenture for Cloud and DevOps, before joining HealthSeq as Director of Engineering.
Arun has extensive experience in various Cloud Platforms, Production Support & DevOps. He has worked on numerous large-scale data-center migrations with a focus on security and compliance, including business continuity, disaster recovery, data replication, and virtualization.